HSHarald Schennach

Harald Schennach

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Harald Schennach has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Peripheral Blood Mononuclear Cells versus Myelomonocytic Cell Line THP-1 to Test for Immumodulatory Properties of Chemicals

    by Sebastian Schroecksnadel, Johanna Gostner, Harald Schennach, Florian Überall, Dietmar Fuchs, Marcel Jenny

    In the last decade there has been a strong increase in the use of engineered nanoparticles, but despite their growing presence and their exposure to humans only little is known about the potential risks for human health. Immune system regulatory circuits play a crucial role in the pathogenesis of a variety of human diseases including autoimmune syndromes and cancer. Interferences of nanoparticles with the immune system may begin at lower dose than toxicity of vital organ function becomes detectable. Moreover, when nanoparticles interfere with immunosurveillance, this will enhance their disease-propagating activities, e.g., when genotoxic effects may promote tumorigenesis. This review article discusses two cell-based methods which could be easily applied for the detection of immunomodulatory properties of nanoparticles. Th1-type cytokine interferon-γ (IFN-γ) is a central regulator within the pro-inflammatory immune response. Among other biochemical events, IFN-γ induces the enzymes GTP-cyclohydrolase I, which gives rise to neopterin production by activated human macrophages, and indoleamine 2,3-dioxygenase (IDO), which converts tryptophan to kynurenine. Accordingly, enhanced tryptophan degradation and neopterin formation are detected in the blood during several disease states involving a Th1-type immune activation such as virus infections, cancer and cardiovascular diseases and are of strong predictive value. To study the immunomodulatory potential of chemicals, unstimulated and stimulated peripheral blood mononuclear cells (PBMC) and myelomonocytic THP-1-Blue cells are applied in vitro. Neopterin formation (by ELISA) and tryptophan degradation (by HPLC) are monitored in the supernatants. In addition, expression of the central signal-transduction element nuclear factor kappa B (NF-κB) was recorded in THP-1-Blue cells, which are transfected with a corresponding NF-κB gene reporter system. Stimulation of PBMC with mitogen phytohaemagglutinin-L (PHA) strongly induces neopterin formation and tryptophan degradation in vitro. Similar effects are observed in THP-1-Blue cells stimulated with lipopolysaccharide and the close correlation with activation of NF-κB becomes evident. Cannabis compound cannabidiol was used to demonstrate the dose-dependent suppression of all the biochemical read-outs in both in vitro cell-based assays. Analysis of neopterin production and tryptophan degradation in freshly isolated human PBMCs is a useful way to measure the influence of compounds or chemicals on the interaction between T-cells and macrophages. The myelomonocytic cell line THP-1-Blue can be used as a convenient alternative, and both assays can be easily applied for the testing of chemicals but the effects of compounds on the T-cell/macrophage interaction will be missed when THP-1-Blue cells are used.


  • Comparison of InVitro Tests for Antioxidant Capacities and Immunomodulatory Properties of Chemicals

    by Sebastian Schroecksnadel, Cathrine Zaknun, Harald Schennach, Marcel Jenny, Dietmar Fuchs

    The increasing utilization of nanoparticles bears potential risks for human health as well as the environment. Many nanoparticles have been shown to influence cellular redox-circuits and immune system homeostasis. Some of them are potent oxidants that lead to oxidative stress, while some of them are potent antioxidants with the capability to scavenge reactive oxygen species. Therefore, the evaluation of the capacity of nanoparticles to interfere with redox-homeostasis and the immune system represents an important strategy to sensitively detect and predict potentially harmful effects of nanoparticles. Our study investigated and compared the antioxidant and immunomodulatory capacity of the well described antioxidants ebselen, sulforaphane (SFN) and vitamin E analogue Trolox employing three different methods, namely the oxygen radical absorbance capacity (ORAC) test, the cell-based antioxidant activity (CAA) assay and a cell culture model using peripheral blood mononuclear cells (PBMC) stimulated or not with 10 μg/ml mitogen phytohemagglutinin (PHA). In the PBMC assay, immunomodulatory effects mediated by compounds were determined by measurement of neopterin production and tryptophan degradation. Trolox showed high antioxidant capacity in the ORAC- and CAA-assay, while ebselen and SFN had almost no such effect. In contrast, Trolox had only little influence on PBMC, whereas ebselen and SFN suppressed neopterin production and tryptophan degradation in a dose dependent manner. This study shows that the three test systems used give different results regarding antioxidant capacities of compounds and their effect on the immune system. The more simple physicochemical tests, ORAC and CAA, cannot fully predict the capacity of compounds to interact with the immune system. This fact needs to be considered when the effects of nanoparticles on biological systems are being tested in vitro.


    • 1 April 2010
      • Vol. 33  (2) , 129-35

    Bovine colostrum modulates immune activation cascades in human peripheral blood mononuclear cells in vitro.

    by Marcel Jenny, Ninfa R Pedersen, Budi J Hidayat, Harald Schennach, Dietmar Fuchs

    Bovine colostrum (BC) is the thick yellow fluid a lactating cow gives to a suckling calf during its first days of life to support the growth of the calf and prevent gastrointestinal infections until the calf has synthesized its own active immune defense system. BC contains a complex system of immune factors and has a long history of use in traditional medicine. In an approach to evaluate the effects of bovine colostrum (BC) on the T-cell/macrophage interplay, we investigated and compared the capacity of BC containing low and high amounts of lactose and lactoferrin to modulate tryptophan degradation and neopterin formation in unstimulated and mitogen-stimulated human peripheral blood mononuclear cells (PBMC). The present study shows significant immunomodulatory effects of these BC preparations in human PBMC, either by enhancing or suppressing the occurrence of a Th-1 type immune response. The amount of lactose present in BC seems to diminish the activity of BC in our test system, since BC with higher amounts of lactose attenuated the stimulatory as well as the suppressive activity of BC.


  • Open Access

    Extracts of Pumpkin (Cucurbita pepo L.) Seeds Suppress Stimulated Peripheral Blood Mononuclear Cells in vitro

    by Christiana Winkler, Katharaina Schroecksnadel, Barbara Wirleitner, Harald Schennach, Dietmar Fuchs

    In the traditional medicine in North America and Mexico, pumpkin seeds have been used as an anthelmintic agent and for supportive treatment in functional disorders of the bladder. Also anti-inflammatory and cardioprotective activity of pumpkin seeds is discussed. Three different extracts of pumpkin seeds were prepared and effects were investigated in unstimulated human peripheral blood mononuclear cells and in cells stimulated with the mitogens phytohaemagglutinin and concanavalin A in vitro. Tryptophan degradation and neopterin concentrations were measured in the supernatants allowing to detect biochemical changes induced by cytokine interferon-γ. Extracts of pumpkin seeds suppressed mitogen-induced neopterin production and tryptophan degradation in a dose-dependent way. Data demonstrate capacity of pumpkin extracts to modulate immunobiochemical pathways induced by interferon- γ. Findings imply an immunoregulatory potential of compounds contained in pumpkin seeds.


  • Open Access

    Human Parvovirus B19 Detection in Asymptomatic Blood Donors: Association with Increased Neopterin Concentrations

    by Harald Schennach, Andrea Judith Lanthaler, Peter Mayersbach, Hanno Ulmer, Karin Muell, Diether Schoenitzer, Dietmar Fuchs, Clara Larcher

    Serum neopterin concentrations were determined in 20,000 blood donations. For the 400 donations with neopterin concentrations above the 98th percenti